MannKind Corporation (NASDAQ:MNKD) Q4 2020 Earnings Conference Call February 25, 2020 9:00 AM ET Company Participants Michael Castagna - CEO Steven Binder - CFO Conference Call Participants Brandon Folkes - Cantor Fitzgerald Oren Livnat - HC Wainwright Steven Lichtman - Oppenheimer Robert Hazlett - BTIG Operator Good morning and welcome to MannKind Corporation Fourth Quarter and Full Year 2020 Earnings Call. As a reminder, this call is being recorded on February 25, 2021, and will be available for playback ...

MannKind Corporation (NASDAQ:MNKD) H.C. Wainwright Bioconnect 2021 Conference January 11, 2021 6:00 AM ET Company Participants Michael Castagna - CEO Conference Call Participants Oren Livnat - H.C. Wainwright Oren Livnat Welcome to the H.C. Wainwright 2021 Bioconnect Conference. My name is Oren Livnat, I am spec pharma analyst here at H.C. Wainwright. It's my pleasure to welcome our presenter MannKind Corporation. With us today is CEO, Michael Castagna. Welcome, Mike. Michael Castagna Thank you for having m ...

MannKind Corporation (NASDAQ:MNKD) Q3 2020 Results Conference Call November 4, 2020 5:00 AM ET Company Participants Michael Castagna - CEO Steven Binder - CFO Conference Call Participants Brandon Folkes - Cantor Fitzgerald Thomas Smith - SVB Leerink Robert Hazlett - BTIG Steven Lichtman - Oppenheimer and Company Operator Good day, everyone. And welcome to the MannKind Corporation Third Quarter 2020 Earnings Call. As a reminder, this call is being recorded on November 4, 2020, and will be available for playb ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------------|------------------------------------------- ...

MannKind Corporation (NASDAQ:MNKD) Oppenheimer Fall Healthcare Life Sciences & MedTech Summit September 21, 2019 10:50 PM ET Company Participants Michael Castagna - CEO Conference Call Participants Steve Lichtman - Oppenheimer & Co. Steve Lichtman Good morning everybody. My name is Steve Lichtman, Senior Medical Devices Analyst at Oppenheimer. Welcome to our Fall Summit. And we’re very happy on the MedTech side to kick off our portion with MannKind Corporation. With us today is CEO, Michael Castagna. I’m go ...

MannKind Corporation (NASDAQ:MNKD) Cantor 2020 Global Virtual Healthcare Conference September 15, 2020 8:40 AM ET Company Participants Michael Castagna - Chief Executive Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Brandon Folkes Welcome everyone to the 2020 Cantor Fitzgerald Virtual Healthcare Conference. Thank you very much for joining us. Next up, we have a fireside chat with MannKind. Joining us from MannKind is CEO, Michael Castagna, Michael, thank you very much for joining u ...

MannKind Corporation (NASDAQ:MNKD) H.C. Wainwright 22nd Annual Global Investment Conference Call September 14, 2020 3:30 PM ET Executives Michael Castagna - Chief Executive Officer Analysts Oren Livnat - H.C. Wainwright Oren Livnat Good afternoon. Welcome back to H.C. Wainwright Twenty Second Annual Global Investment Conference. My name is Oren Livnat. I am a specialty pharmaceuticals analyst here. And I am happy to our next company. It's MannKind. With us today is CEO, Michael Castagna. I do cover the comp ...

MannKind Corporation (NASDAQ:MNKD) Q2 2020 Earnings Conference Call August 5, 2020 5:00 PM ET Company Participants Michael Castagna - Chief Executive Officer Steve Binder - Chief Financial Officer Conference Call Participants Dylan Dupuis - SVB Leerink Brandon Folkes - Cantor Fitzgerald Robert Hazlett - BTIG, LLC Operator Good day, everyone. Welcome to the MannKind Corporation Second Quarter 2020 Earnings Call. As a reminder, this call is being recorded on August 5, 2020, and will be available for playback ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 000-50865 MannKind Corporation (Exact name of registrant as specified in its charter) Delaware 13-3607736 (State or other jurisdiction of inc ...